Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 12 March 2020. Andreas Papadopoulos.

Executive Summary

LivaNova announced its vagus nerve stimulation system Symmetry has earned the CE mark to treat chronic or recurrent depression. See what Andreas Papadopoulos, clinical director at Somerset Partnership National Health Service Foundation Trust, said about the device here.

"With depression affecting so many people in the UK and so many patients suffering from symptoms despite traditional therapy, we were excited to develop a treatment pathway that can be replicated throughout the country, giving more patients with difficult-to-treat depression access to VNS therapy and Symmetry. Working with Ear, Nose and Throat (ENT) surgical services enabled us to achieve swift and expert implantation of Symmetry devices for both patients." – Andreas Papadopoulos, clinical director, Somerset Partnership National Health Service Foundation Trust

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts